Visen Pharmaceuticals Ltd. (T06)
Market Closed
17 Jul, 20:00
XFRA XFRA Primary €
2. 02
-0.06
-2.8846%
€
278.42M Market Cap
- P/E Ratio
- Div Yield
0 Volume
- Eps
€ 2.08
Previous Close Want to track T06 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Visen Pharmaceuticals Ltd. (T06) Statistics
Valuation metrics
Market Cap 278.42M
Enterprise value -177.24M
Trailing P/E (ttm) -
Forward P/E -
PEG ratio -
Price/Sales (ttm) 2.52
Price/Book (mrq) 0.08
Enterprise Value/Revenue -1,074.18
Enterprise Value/EBITDA 0.74
Overview
Shares outstanding 109.04M
Float 2.65M
Shares short -
% Held by insiders 0.49%
% Held by institutions 0.47%
Average volume (10 days) -
Average volume (90 days) -
Price summary
52-Week low 2
52-Week high 5.55
Beta -
50-Day moving average 3.66
200-Day moving average 4.52
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2024
Profitability
Profit margin -1.53%
Operating margin 0.67%
Operational effectiveness
Return on assets -0.26%
Return on equity -0.33%
Income Statement
Revenue (ttm) 14.07M
Revenue per share (ttm) 11.93
Quarterly revenue growth (yoy) -
Gross profit (ttm) 14.07M
EBITDA -5.87M
Net income to common (ttm) -21.57M
Diluted EPS (ttm) -0.18
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 43.94M
Total cash per share (mrq) 37.23
Total debt (mrq) 460.98K
Total Debt/Equity (mrq) 0.93
Current ratio (mrq) 5.52%
Book value per share (mrq) 31
Cash Flow
Cash flow statement -27.54M
Levered free cash flow (LFCF) -253.42M
